Viracta, a California biotech oncology firm, is laying off every remaining employee and shutting down after its cash stores ...

The company, co-founded by Cleveland Clinic in 2013, had a couple major objectives for the funding: expanding the commercial ...

Biotech firm Phytome Life Sciences plans to establish a headquarters in Saudi Arabia in a bid to accelerate commercialization ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

M&A in biotech and pharma is expected to surge in late 2024 as regulatory uncertainties ease. Discover trends, key players, and areas of high interest.

Oxford Cannabinoid Technologies is shedding its old skin. Having delisted its stock last year, the biotech is rebranding as ...

New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...

For example, Brittany found that drugs being developed by Generate were modified versions of existing antibodies, and that ...

News of the layoffs come just one day after the company reported a 5% year over year revenue increase — boosting revenue to ...

The fund aims to build a portfolio of 20-25 companies that address gaps in services and products across pharmaceuticals, ...

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...